Edith Heard

Current position

Group leader, Research Director (DR1), Unit Director (Genetics and Developmental Biology, UMR3215), Professor at the Collège de France

Host institution

Curie Institute, Paris, France CNRS, France


Mammalian Developmental Epigenetics



          X-inactivation is a process by which one of the two X chromosomes is transcriptionally silenced during early development in female mammals. It allows for dosage compensation between XX females and XY males. Edith Heard is studying this paradigm for developmental epigenetics to gain insights into the fundamental mechanisms that underlie the dynamics of gene expression during development and cellular differentiation, as well as during tumorigenesis.

Read more


• 1990 : Ph. D. Imperial Cancer Research Fund laboratory, London, United Kingdom, Mike Fried’s lab

• 1990-1993 : Post-doctoral fellow, Pasteur Institute, Paris, France, Philip Avner's lab

• 1993 : Appointed CNRS staff scientist, Pasteur Institute, Paris, France, Philip Avner's lab

• 2001 : Appointed Group leader at the Curie Institute, Paris, France

• 2010 Nommée Directrice de l'UMR3215/U934 à l’Institut Curie, Paris, France

• 2013 Nommée Professeur au Collège de France, Paris, France


• La Ligue Prize “René et Andrée DUQUESNE”, 2017 

• European Society of Human Genetics Award, 2017

• Elected Fellow of the Royal Society, 2013

• Grand Prize of the Allianz Foundation, Institut de France, 2013

• Grand Prize of the Foundation for Medical Research (FRM), 2012

• Advanced Grant from the European Research Council (ERC), 2010

• Silver Medal (Best Confirmed Researchers), CNRS, 2008

• Elected as an EMBO member, 2005